One of the more exciting opportunities in medical technology is using a virus to carry genetic information in the form of DNA and RNA in the cells. One of the most commonly used viruses is ...
Quality by design is critical for cell and gene therapy manufacturing where process controls directly influence product ...
Academic medical centers must play a crucial part in overcoming cell and gene therapy development hurdles by establishing institutional frameworks that offer comprehensive support extending beyond ...
Sangamo Therapeutics ran out of cash. Eli Lilly and Astellas want the science it spent decades building.
The special properties of methylcellulose foam could make it a vehicle for bedside genetic engineering, according to a proof-of-principle study from bioengineers at Fred Hutch Cancer Center. In the ...
StitchR, a new gene therapy technique, delivers large genes in two parts to treat muscular dystrophies by restoring critical proteins in animal models. Gene therapy can effectively treat various ...
Discusses Updated Phase 1/2 Data for NGN-401 Gene Therapy in Rett Syndrome June 29, 2026 8:00 AM EDTCompany ParticipantsLina ...
CHICAGO, Nov 8 (Reuters) - A single infusion of CRISPR Therapeutics' (CRSP.BN), opens new tab experimental gene therapy was safe and reduced levels of harmful LDL cholesterol and triglycerides by half ...
Sangamo Therapeutics, a pioneering gene editing biotech company in the Bay Area, has filed for Chapter 11 bankruptcy protection and agreed to sell some of its programs and platforms to Eli Lilly and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results